2021/01/12 | Press Release – ArchiMed buys Germany’s Zyto Group of Cancer Diagnostics companies in partnership with owners and management
With ArchiMed’s backing, the group is expected to rapidly become a European leader in diagnostics for cutting-edge, precision medical treatments for cancer. January 12, 2021 – Private equity healthcare specialist, ArchiMed, announces its acquisition of the Zyto group of companies, a fully integrated developer, manufacturer and distributor of technologically advanced cancer diagnostics tests and equipment…